EUVIMEDEUVIMED entdecken
Crossref

Establishment and characterization of NCC-GCTB14-C1 and NCC-GCTB15-C1: two novel patient-derived cell lines of giant cell tumor of bone

Shuhei Iwata, Takuya Ono, Rei Noguchi, Julia Osaki, Yuki Adachi, Yomogi Shiota, Shintaro Iwata, Shogo Nishino, Akihiko Yoshida, Seiji Ohtori, Akira Kawai, Tadashi Kondo

Human Cell · 2024

DOI: 10.1007/s13577-024-01150-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Cell, 2024. Verfasst von Shuhei Iwata und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rare Cancer Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. Hauptthemen laut MEDLINE: Giant Cell Tumor of Bone, Bone Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Giant Cell Tumor of BoneBone NeoplasmsHumansCell Line, TumorCell ProliferationCell MovementMutationMaleAntineoplastic AgentsDrug Screening Assays, AntitumorSpheroids, CellularFemaleHistones

Stichwörter der Autor:innen

Antitumor drug screeningCell linesGiant cell tumor of bonePatient-derived cacner modelPreclinical model

Substanzen

H3-3A protein, humanAntineoplastic AgentsHistones

Autor:innen und Institutionen

  • Division of Rare Cancer Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Department of Orthopedic Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8670, Japan.
  • Department of Musculoskeletal Oncology and Rehabilitation Medicine, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Department of Diagnostic Pathology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Division of Rare Cancer Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. takondo@ncc.go.jp.

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Iwata, S., Ono, T., Noguchi, R., Osaki, J., Adachi, Y., Shiota, Y., Iwata, S., Nishino, S., Yoshida, A., Ohtori, S., Kawai, A., & Kondo, T. (2024). Establishment and characterization of NCC-GCTB14-C1 and NCC-GCTB15-C1: two novel patient-derived cell lines of giant cell tumor of bone. Human Cell. https://doi.org/10.1007/s13577-024-01150-2

Vancouver

Iwata S, Ono T, Noguchi R, Osaki J, Adachi Y, Shiota Y, et al. Establishment and characterization of NCC-GCTB14-C1 and NCC-GCTB15-C1: two novel patient-derived cell lines of giant cell tumor of bone. Human Cell. 2024. doi:10.1007/s13577-024-01150-2

BibTeX
@article{Iwata2024,
  author = {Iwata, Shuhei and Ono, Takuya and Noguchi, Rei and Osaki, Julia and Adachi, Yuki and Shiota, Yomogi and Iwata, Shintaro and Nishino, Shogo and Yoshida, Akihiko and Ohtori, Seiji and Kawai, Akira and Kondo, Tadashi},
  title = {Establishment and characterization of NCC-GCTB14-C1 and NCC-GCTB15-C1: two novel patient-derived cell lines of giant cell tumor of bone},
  journal = {Human Cell},
  year = {2024},
  doi = {10.1007/s13577-024-01150-2}
}
Kostenlos starten →